NCT06263647 Launching the Houston Hospital-Based Violence Intervention Program (Houston-HVIP): Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence
| NCT ID | NCT06263647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Firearm Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 274 participants |
| Start Date | 2025-09-16 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 274 participants in total. It began in 2025-09-16 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Houston-HVIP). Using a randomized controlled trial, the study will assess the effectiveness of Houston-HVIP in reducing violent reinjury and improving behavioral, mental, and physical health outcomes over a 12-month follow-up period among those enrolled in the study in ages 16-35 years of age.
Eligibility Criteria
Inclusion Criteria: * presented for a gunshot injury stemming from community violence at Memorial Hermann Hospital * English or Spanish-speaking * provide informed voluntary consent to participate in the study * live in Harris County at time of enrollment * live within 40-mile radius of Memorial Hermann Hospital- Texas Medical Center Exclusion Criteria: * presenting for a firearm injury arising from a self-inflicted gunshot or unintentional gun violence * actively detained by criminal justice systems at time of enrollment
Contact & Investigator
Sandra McKay, MD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT06263647 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 40 Years, studying Firearm Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06263647 currently recruiting?
Yes, NCT06263647 is actively recruiting participants. Contact the research team at Sandra.McKay@uth.tmc.edu for enrollment information.
Where is the NCT06263647 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06263647 clinical trial?
NCT06263647 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Sandra McKay, MD at The University of Texas Health Science Center, Houston. The trial plans to enroll 274 participants.